These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38945805)

  • 21. Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease.
    Kobari M; Fukuuchi Y; Shinohara T; Nogawa S; Takahashi K
    Arch Neurol; 1992 Jul; 49(7):725-30. PubMed ID: 1497499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.
    Warnecke T; Oelenberg S; Teismann I; Hamacher C; Lohmann H; Ringelstein EB; Dziewas R
    Mov Disord; 2010 Jul; 25(9):1239-45. PubMed ID: 20629130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
    Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graph Theoretical Analysis of Semantic Fluency in Patients with Parkinson's Disease.
    Zhang G; Ma J; Chan P; Ye Z
    Behav Neurol; 2022; 2022():6935263. PubMed ID: 35502419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS; Sedlacik J; Boelmans K; Forkert ND
    Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.
    Wittstock M; Pohley I; Walter U; Grossmann A; Benecke R; Wolters A
    J Neural Transm (Vienna); 2013 Mar; 120(3):453-61. PubMed ID: 22892823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
    Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
    Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cognitive deficits in progressive supranuclear palsy].
    Kułakowska A; Pyd E; Halicka D; Pogorzelski R; Drozdowski W
    Neurol Neurochir Pol; 2003; 37 Suppl 5():203-10. PubMed ID: 15098348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
    Tommasini L; Bonaccorsi J; Del Prete E; Cintoli S; Pagni C; Mazzucchi S; Palermo G; Morganti R; Frosini D; Siciliano G; Tognoni G; Ceravolo R
    Clin Neuropsychol; 2023 Aug; 37(6):1207-1220. PubMed ID: 35997036
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic potential of automated tractography in progressive supranuclear palsy variants.
    Potrusil T; Krismer F; Beliveau V; Seppi K; Müller C; Troger F; Göbel G; Steiger R; Gizewski ER; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2020 Mar; 72():65-71. PubMed ID: 32113070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach.
    Vaccaro MG; Sarica A; Quattrone A; Chiriaco C; Salsone M; Morelli M; Quattrone A
    J Neuropsychol; 2021 Sep; 15(3):301-318. PubMed ID: 33231380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa-induced oromandibular dystonia in progressive supranuclear palsy.
    Tan EK; Chan LL; Wong MC
    Clin Neurol Neurosurg; 2003 Apr; 105(2):132-4. PubMed ID: 12691807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ; Siuda J
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
    Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL
    Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.